The authors thank Philipp Herrmann, MD, PhD, Department of Ophthalmology, University Bonn, Bonn, Germany, provided excellent patient care; Markus N. Preising, PhD, Department of Ophthalmology, Justus-Liebig University Giessen, Giessen, Germany, established a large database of IRD patients in Giessen. The research nurses Naike Cavriani, Laura Wirtz, and Kristina Küpper, Department of Ophthalmology, University Bonn, Bonn, Germany, performed high-quality SD-OCT imaging. Part of the OCT scans was collected within the PERCEIVE Registry (EUPAS31153,
https://catalogues.ema.europa.eu/node/3021/data-management) funded by Novartis Pharma Suisse GmbH, Switzerland.
Supported by the German Research Foundation under Germany's Excellence Strategy - EXC-2047/1 - 390685813 and - EXC2151 - 390873048. This work was supported by the Open Access Publication Fund of the University of Bonn.
Disclosure: G. Pinedo-Diaz, None; B. Lorenz, Novartis Pharma (F, C, R), Janssen/Johnson & Johnson (C, R), Pfizer (R); S.H. Künzel, Novartis Pharma (C), Chiesi GmbH (R), Apellis (R); S. Thiele, Heidelberg Engineering (F, R), Novartis Pharma GmbH (F, R), Allergan (R), Bayer AG (R), Optos (F), CenterVue (F), Zeiss (F); S. Ortega-Cisneros, None; E. Bayro Corrochano, None; F.G. Holz, Novartis Pharma (F), Heidelberg Engineering (C, R), Optos (R), Zeiss (C, R), iCare/Centervue (R), 4D Molecular Therapeutics (C), Euretina (S), German Ophthalmological Society (S), Macula Society (S); A. Effland, relios.vision GmbH (O, P)